Skip to main content
Top
Published in: Clinical Rheumatology 12/2007

01-12-2007 | Original Article

Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus

Authors: Hasan Otukesh, Majid Chalian, Rozita Hoseini, Hamid Chalian, Nakysa Hooman, Arash Bedayat, Reza Salman Yazdi, Saeed Sabaghi, Saeed Mahdavi

Published in: Clinical Rheumatology | Issue 12/2007

Login to get access

Abstract

We reported a series of ten patients with lupus nephritis (five patients in the relapse phase and five in the remission phase) and measured the macrophage migration inhibitory factor (MIF), an important pro-inflammatory cytokine with probable role in the pathogenesis of many inflammatory diseases, in their urine samples. MIF/creatinine (Cr) ratio directly correlated with disease activity and it does not have any significant difference between inactive disease and normal ones. We found that the urine MIF/Cr ratio not only differentiates active disease from inactive disease and normal ones but also correlates with the activity indices of renal pathology.
Literature
1.
go back to reference Foster MH, Kelley VR (1999) Lupus nephritis: update on pathogenesis and disease mechanisms. Semin Nephrol 19:173–181PubMed Foster MH, Kelley VR (1999) Lupus nephritis: update on pathogenesis and disease mechanisms. Semin Nephrol 19:173–181PubMed
2.
go back to reference Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449–460CrossRefPubMed Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449–460CrossRefPubMed
3.
go back to reference Gregersen PK, Bucala R (2003) Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48:1171–1176CrossRefPubMed Gregersen PK, Bucala R (2003) Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48:1171–1176CrossRefPubMed
4.
go back to reference Donn RP, Ray DW (2004) Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182:1–9CrossRefPubMed Donn RP, Ray DW (2004) Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182:1–9CrossRefPubMed
5.
go back to reference Morand EF (2005) New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Intern Med J 35:419–426CrossRefPubMed Morand EF (2005) New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Intern Med J 35:419–426CrossRefPubMed
6.
go back to reference Hoi AY, Morand EF, Leech M (2003) Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol 81:367–373CrossRefPubMed Hoi AY, Morand EF, Leech M (2003) Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol 81:367–373CrossRefPubMed
7.
go back to reference Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM et al (2002) Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 13:S7–S13PubMed Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM et al (2002) Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 13:S7–S13PubMed
8.
go back to reference Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K et al (2000) Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5:397–403PubMed Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K et al (2000) Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5:397–403PubMed
Metadata
Title
Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus
Authors
Hasan Otukesh
Majid Chalian
Rozita Hoseini
Hamid Chalian
Nakysa Hooman
Arash Bedayat
Reza Salman Yazdi
Saeed Sabaghi
Saeed Mahdavi
Publication date
01-12-2007
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0632-z

Other articles of this Issue 12/2007

Clinical Rheumatology 12/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.